Skip to main content

Advertisement

Log in

Enamel matrix derivative alone or in combination with a bioactive glass in wide intrabony defects

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

This controlled clinical study investigated the clinical and radiographic outcome of wide intrabony periodontal defects treated by enamel matrix derivatives alone or in combination with a bioactive glass over a period of 8 months. Twenty-three chronic periodontitis patients, who received initial therapy and had radiographical interproximal defects with an associated probing depth of 6 mm or more and an intrabony component of at least 4 mm, were included. Each of the patients, contributing at least one intrabony defect, was treated with either enamel matrix derivative alone (group 1, n=10) or the combination (group 2, n=13). In both groups, all clinical and radiographical parameters were improved. Groups 1 and 2 presented a mean pocket reduction of 5.03±0.89 and 5.73±0.80 mm, recession of 0.97±0.24 and 0.56±0.18 mm, relative attachment gain of 4.06±1.06 and 5.17±0.85 mm, and radiographic bone gain of 2.15±0.42 and 2.76±0.69 mm, respectively. An intergroup comparison revealed significant differences for all of the parameters, yielding a more favorable outcome towards the combined approach. Within the limits of the study, both treatments resulted in marked clinical and radiographical improvements, but combined treatment seemed to enhance the results in the treatment of wide intrabony defects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Kenney EB, Madzarevic M (2001) The effectiveness of enamel matrix proteins used in combination with bovine porous bone mineral in the treatment of intrabony defects in humans. J Clin Periodontol 28:1016–1022

    Article  PubMed  Google Scholar 

  2. Cattaneo V, Rota C, Silvestri M, Piacentini C, Forlino A, Gallanti A, Rasperini G, Cetta G (2003) Effect of enamel matrix derivative on human periodontal fibroblasts: proliferation, morphology and root surface colonization. An in vitro study. J Periodontal Res 38:568–574

    Article  PubMed  Google Scholar 

  3. Christgau M, Schmalz G, Reich E, Wenzel A (1995) Clinical and radiographical split-mouth-study on resorbable versus non-resorbable GTR-membranes. J Clin Periodontol 22:306–315

    Article  PubMed  Google Scholar 

  4. Cochran DL, Jones A, Heijl L, Mellonig JT, Schoolfield J, King GN (2003) Periodontal regeneration with a combination of enamel matrix proteins and autogenous bone grafting. J Clin Periodontol 74:1269–1281

    Article  Google Scholar 

  5. Cochran DL, King GN, Schoolfield J, Velasquez-Plata D, Mellonig JT, Jones A (2003) The effect of enamel matrix proteins on periodontal regeneration as determined by histological analyses. J Clin Periodontol 74:1043–1055

    Article  Google Scholar 

  6. Donos N, Sculean A, Glavind L, Reich E, Karring T (2003) Wound healing of degree III furcation involvements following guided tissue regeneration and/or Emdogain. A histologic study. J Clin Periodontol 30:1061–1068

    Article  PubMed  Google Scholar 

  7. Fetner A, Hartigan M, Low S (1994) Periodontal repair using Perioglass in non-human primates: clinical and histological observations. Compendium (Newt. Pa.) 7:932–938

    Google Scholar 

  8. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D (2001) A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry. J Clin Periodontol 72:25–34

    Article  Google Scholar 

  9. Garrett S (1996) Periodontal regeneration around natural teeth. In: Newman MG (ed) Annals of periodontology. The American Academy of Periodontology, Chicago, pp 621–666

    Google Scholar 

  10. Gunsolley J, Elswick RK, Davenport JM (1998) Equivalence and superiority testing in regeneration clinical trials. J Clin Periodontol 69:521–527

    Google Scholar 

  11. Haase H, Bartold PM (2001) Enamel matrix derivative induces matrix synthesis by cultured human periodontal fibroblast cells. J Clin Periodontol 72:341–348

    Article  Google Scholar 

  12. Hammarstrom L (1997) Enamel matrix, cementum development and regeneration. J Clin Periodontol 24:658–668

    Article  PubMed  Google Scholar 

  13. Heden G (2000) A case report study of 72 consecutive Emdogain-treated intrabony defects: clinical and radiographic findings after 1 year. Int J Periodontics Restor Dent 20:127–139

    Google Scholar 

  14. Heijl L (1997) Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 24:693–696

    Article  PubMed  Google Scholar 

  15. Heijl L, Heden G, Svardström G, Östgren A (1997) Enamel matrix derivative (Emdogain) in the treatment of intrabony periodontal defects. J Clin Periodontol 24:705–714

    Article  PubMed  Google Scholar 

  16. Karatzas S, Zavras A, Greenspan D, Amar S (1999) Histologic observations of periodontal wound healing after treatment with PerioGlas in nonhuman primates. Int J Periodontics Restor Dent 19:489–499

    Google Scholar 

  17. Kılıç AR, Efeoğlu E, Yılmaz S (1997) Guided tissue regeneration in conjunction with hydroxyapatite-collagen grafts for intrabony defects. A clinical and radiological evaluation. J Clin Periodontol 24:372–383

    Article  PubMed  Google Scholar 

  18. Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB (2000) A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Clin Periodontol 71:1110–1116

    Article  Google Scholar 

  19. Lindhe J, Westfelt E, Nyman S, Socransky SS, Heijl L, Bratthall G (1982) Healing following surgical/non-surgical treatment of periodontal disease. A clinical study. J Clin Periodontol 9:115–128

    Article  PubMed  Google Scholar 

  20. Mellonig JT (1999) Enamel matrix derivative for periodontal reconstructive surgery: technique and clinical and histologic case report. Int J Periodontics Restor Dent 19:9–19

    Google Scholar 

  21. Mühlemann HR, Son S (1971) Gingival sulcus bleeding: a leading symptom in initial gingivitis. Helv Odontol Acta 15:107–112

    PubMed  Google Scholar 

  22. Nevins ML, Camelo M, Nevins M, King CJ, Oringer RJ, Schenk RK, Fiorellini JP (2000) Human histologic evaluation of bioactive ceramic in the treatment of periodontal osseous defects. Int J Periodontics Restor Dent 20:458–467

    Google Scholar 

  23. Pietruska MD (2001) A comparative study on the use of Bio-Oss and enamel matrix derivative (Emdogain) in the treatment of periodontal bone defects. Eur J Oral Sci 109:178–181

    Article  PubMed  Google Scholar 

  24. Pontoriero R, Wennström J, Lindhe J (1999) The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 26:833–840

    Article  PubMed  Google Scholar 

  25. Quintero G, Mellonig JT, Gambill VM, Pelleu GB Jr (1982) A six-month clinical evaluation of decalcified freeze-dried bone allografts in periodontal osseous defects. J Clin Periodontol 53:726–730

    Google Scholar 

  26. Rosen P, Reynolds MA (2002) A retrospective case series comparing the use of demineralized freeze-dried bone allograft and freeze-dried bone allograft combined with enamel matrix derivative for the treatment of advanced osseous lesions. J Clin Periodontol 73:942–949

    Article  Google Scholar 

  27. Scheyer ET, Velasquez-Plata D, Brunsvold MA, Lasho DJ, Mellonig JT (2002) A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects. J Clin Periodontol 73:423–432

    Article  Google Scholar 

  28. Sculean A, Donos N, Blaes A, Lauermann M, Reich E, Brecx M (1999) Comparison of enamel matrix proteins an bioabsorbable membranes in the treatment of intrabony defects. A split-mouth study. J Clin Periodontol 70:255–262

    Article  Google Scholar 

  29. Sculean A, Donos N, Windisch P, Gera I, Brecx M, Reich E, Karring T (1999) Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 34:310–322

    Article  PubMed  Google Scholar 

  30. Sculean A, Reich E, Chiantella CG, Brecx M (1999) Treatment of intrabony periodontal defects with an enamel matrix protein derivative (Emdogain): a report of 32 cases. Int J Periodontics Restor Dent 19:157–163

    Google Scholar 

  31. Sculean A, Chiantella GC, Windisch P, Donos N (2000) Clinical and histologic evaluation of treatment of intrabony defects with an enamel matrix protein derivative (Emdogain). Int J Periodontics Restor Dent 20:375–381

    Google Scholar 

  32. Sculean A, Donos N, Brecx M, Reich E, Karring T (2000) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. An experimental study in monkeys. J Clin Periodontol 27:466–472

    Article  PubMed  Google Scholar 

  33. Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E (2001) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 28:397–403

    Article  PubMed  Google Scholar 

  34. Sculean A, Barbe G, Chiantella GC, Arweiler NB, Berakdar M, Brecx M (2002) Clinical evaluation of an enamel matrix derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. J Clin Periodontol 73:401–408

    Article  Google Scholar 

  35. Sculean A, Windisch P, Keglevich T, Fabi B, Lundgren E, Lyngstadaas PS (2002) Presence of an enamel matrix protein derivative on human teeth following periodontal surgery. Clin Oral Investig 6:183–187

    Article  PubMed  Google Scholar 

  36. Sculean A, Windisch P, Keglevich T, Chiantella CG, Gera I, Donos N (2003) Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative combined with a bovine derived xenograft. Int J Periodontics Restor Dent 23:47–55

    Google Scholar 

  37. Sculean A, Pietruska M, Schwartz F, Willershausen B, Arweiler NB, Auschill TM (2005) Healing of human intrabony defects following regenerative periodontal therapy with an enemal matrix protein derivative alone and combinated with a bioactive glass. J Clin Periodontol 32:111–117

    Article  PubMed  Google Scholar 

  38. Sculean A, Windisch P, Keglevich Gera I (2005) Clinical and histologic evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. Int J Periodontics Restor Dent 25:139–147

    Google Scholar 

  39. Silness J, Löe H (1964) Periodontal disease in pregnancy (II). Correlation between oral hygiene and periodontal conditioning. Acta Odontol Scand 22:121–135

    Article  PubMed  Google Scholar 

  40. Silverstein LH (2005) Suture selection for optimal flap closure and tissue healing. Perio-implant showcase. Pract Periodontics Aesthet Dent 16:2–3

    Google Scholar 

  41. Silvestri M, Ricci G, Rasperini G, Sartori S, Cattaneo V (2000) Comparison of treatments of intrabony defects with enamel matrix derivative, guided tissue regeneration with a nonresorbable membrane and Widman modified flap. A pilot study. J Clin Periodontol 27:603–610

    Article  PubMed  Google Scholar 

  42. Tonetti MS, Lang NP, Cortellini P, Suvan JE, Adrian P, Dubravec D, Fonzar A, Fourmousis I, Mayfield L, Rossi R, Silvestri M, Tiedman C, Topoll H, Vangsted T, Walkamm B (2002) Enamel matrix proteins in the regenerative therapy of deep intrabony defects. A multicenter in the regenerative therapy of deep intrabony defects. A multicenter randomized controlled clinical trial. J Clin Periodontol 9:317–325

    Article  Google Scholar 

  43. Velasquez-Plata D, Scheyer TE, Mellonig JT (2002) Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Clin Periodontol 73:433–440

    Article  Google Scholar 

  44. Wikesjö UME, Selvig KA (1999) Periodontal wound healing and regeneration. Periodontol 2000 19:21–39

    Article  PubMed  Google Scholar 

  45. Wilson J, Low (1992) Bioactive ceramics for periodontal treatment: comparative study in the patus monkey. J Appl Biomater 3:123–129

    Article  PubMed  Google Scholar 

  46. Wilson J, Clark AE, Hall M, Hench LL (1993) Tissue response to Bioglass endosseous ridge maintenance implants. J Oral Implantol 19:295–302

    PubMed  Google Scholar 

  47. Yılmaz S, Kuru B, Altuna-Kırac E (2003) Enamel matrix proteins in the treatment of periodontal sites with horizontal type of bone loss. J Clin Periodontol 30:197–206

    Article  PubMed  Google Scholar 

  48. Yukna RA, Mellonig J (2000) Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 71:752–759

    Article  PubMed  Google Scholar 

  49. Zetterström O, Andersson C, Eriksson C (1997) Clinical safety of enamel matrix derivative (EMDOGAIN) in the treatment of periodontal defects. J Clin Periodontol 24:697–704

    Article  PubMed  Google Scholar 

  50. Zucchelli G, Amore C, Montebugnoli L, De Sanctis M (2003) Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: a comparative controlled clinical trial. J Periodontol 74:1725–1735

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

The authors would like to thank Asst. Prof. Cem S. Sütcü for his statistical support in analyzing the data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bahar Kuru.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuru, B., Yılmaz, S., Argın, K. et al. Enamel matrix derivative alone or in combination with a bioactive glass in wide intrabony defects. Clin Oral Invest 10, 227–234 (2006). https://doi.org/10.1007/s00784-006-0052-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-006-0052-5

Keywords

Navigation